Inflammatory disorders

Trial asthma drug targets lung inflammation

University of Adelaide researchers at the Royal Adelaide Hospital are involved in the world's biggest study of its kind investigating a possible new treatment for asthma.

Diseases, Conditions, Syndromes

Cost of medication and stigma leading asthma sufferers to risk health

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ ...

Diseases, Conditions, Syndromes

Positive results trial for new asthma treatment

Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the ...

Diseases, Conditions, Syndromes

Asthma rates double for WTC first responders

The American Journal of Industrial Medicine recently published a study showing that World Trade Center (WTC) responders suffer from asthma at more than twice the rate of the general U.S. population as a result of their exposure ...

Medications

FDA phases out inhaler due to environmental impact

(AP) -- Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's atmosphere.

page 24 from 26